Ms. Franson will help biopharma clients design a phased approach to inform and execute clinical development plans, amplify awareness within clinician and patient communities, and form partnerships necessary to accelerate clinical trial completion.
After 8 years in leadership roles at Vaniam Group, Herzog’s appointment demonstrates agency’s continued focus on client service, operational excellence, and healthy growth.
At 9th annual WLO reception, Vaniam Group makes progress on $1.35 million endowment pledge, expands WLO to be a year-round community supporting female contributions in the field of oncology.
Dr Nze Is Second Annual Recipient of Grant Dedicated to Black, African, or African American Cancer Researchers; Will Research Barriers to Minority Participation in Lymphoma Clinical Trials.
Based on 2022 employee survey data, Vaniam Group scored among top 20 US health companies.
Vaniam Group Receives Recognition for Second Consecutive Year.
Vaniam Group Funds Annual Award Given to Black, African, or African American Cancer Researchers.
Vaniam Group to Match $100,000 for Young Investigator Award Endowment to Accelerate Future Oncology Research.
